JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases
|
|
- Annice Cook
- 6 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (1999) 43, JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases Panagiota Giakkoupi a, Eva Tzelepi a, Nicholas J. Legakis b and Leonidas S. Tzouvelekis b * a Department of Bacteriology, Hellenic Pasteur Institute; b Laboratory of Antimicrobial Agents, Department of Microbiology, Medical School, University of Athens, M. Asias 75, 11527, Athens, Greece In SHV-type -lactamases, position 276 (in Ambler s numbering scheme) is occupied by an asparagine (Asn) residue. The effect on SHV-1 -lactamase and its extended-spectrum derivative SHV-5 of substituting an aspartic acid (Asp) residue for Asn276 was studied. Mutations were introduced by a PCR-based site-directed mutagenesis procedure. Wild-type SHV-1 and -5 -lactamases and their respective Asn276 Asp mutants were expressed under isogenic conditions by cloning the respective bla genes into the pbcsk( ) plasmid and transforming Escherichia coli DH5. Determination of IC 50 showed that SHV-1(Asn276 Asp), compared with SHV-1, was inhibited by 8- and 8.8-fold higher concentrations of clavulanate and tazobactam respectively. Replacement of Asn276 by Asp in SHV-5 -lactamase caused a ten-fold increase in the IC 50 of clavulanate; the increases in the IC 50 s of tazobactam and sulbactam were 10- and 5.5-fold, respectively. -Lactam susceptibility testing showed that both Asn276 Asp mutant enzymes, compared with the parental -lactamases, conferred slightly lower levels of resistance to penicillins (amoxycillin, ticarcillin and piperacillin), cephalosporins (cephalothin and cefprozil) and some of the expanded-spectrum oxyimino -lactams tested (cefotaxime, ceftriaxone and aztreonam). The MICs of ceftazidime remained unaltered, while those of cefepime and cefpirome were slightly elevated in the clones producing the mutant -lactamases. The latter clones were also less susceptible to penicillin-inhibitor combinations. Asn276 Asp mutation was associated with changes in the substrate profiles of SHV-1 and SHV-5 enzymes. Based on the structure of TEM-1 -lactamase, the potential effects of the introduced mutation on SHV-1 and SHV-5 are discussed. Introduction Combinations of -lactam antibiotics with -lactamase inhibitors are useful in treating infections caused by -lactamase-producing bacteria. 1 Among the clinically important -lactamases in enterobacteria are the plasmidmediated TEM-1/2 and SHV-1 penicillinases (group 2b), and their extended-spectrum derivatives (group 2be). 2 These enzymes are susceptible to the inhibitory activity of clavulanic acid and tazobactam. The intensive use of penicillin-inhibitor combinations, however, has facilitated the emergence of inhibitor-resistant -lactamase variants (group 2br). 2 Most of the mutant enzymes that occur in vivo have been derived from TEM-1 or TEM-2 penicillinases by replacement of Met69 by Ile, Leu or Val, 3 8 Arg244 by Cys or Ser, 7 12 and Asn276 by Asp 4,7,8 (numbering is according to Ambler et al. 13 ). Similar inhibitorresistant mutants of SHV-type -lactamases have not yet been found in clinical strains. Studies with SHV-type laboratory mutant enzymes, obtained either spontaneously or by site-specific mutagenesis, showed that Met69 Ile or Val and Arg244 Ser or Cys substitutions confer resistance to mechanism-based inhibitors, as for TEM - lactamases Characterization of an in-vitro constructed mutant of TEM-1 -lactamase showed that Asn276 Asp substitution conferred resistance to clavulanate and reduced hydrolytic activity against penicillins and cephalosporins. 17 In addition, Asn276 Gly replacement in OHIO-1 - lactamase (an enzyme of the SHV family) modified *Corresponding author. Tel: 33-(1) ; Fax: 33-(1) ; Lstbact@hotmail.com 1999 The British Society for Antimicrobial Chemotherapy 23
2 P. Giakkoupi et al. inhibitor binding specificity and altered affinity for penicillins. 18 In this work, we examined the effect of Asn276 Asp substitution in SHV-1 -lactamase and its extendedspectrum derivative SHV-5. performed by the dideoxy chain termination method using a Sequenase 2.0 kit (United States Biochemical Corp., Cleveland, OH, USA). To confirm the lack of unwanted changes, the complete nucleotide sequences of both strands of the mutant genes were determined. Materials and methods Bacterial strains, plasmids and cloning of -lactamase genes The Escherichia coli DH5 strain ( deor, enda1, gyra96, hsdr17 (r k m k ), reca1, rela1, supe44, thi-1 (lacizyaargfv169), 80 lacz M15, F, ) was used to express the wild-type and mutant -lactamases. The plasmids used in the study are described in Table I. To achieve isogenic conditions, 1.4 kb SmaI ClaI fragments, encompassing the coding and promoter regions of bla SHV-1 and bla SHV-5, were purified from low-melting point agarose and ligated into the multicloning site of pbcsk( ). The resulting plasmids were used to transform E. coli DH5 competent cells. -Lactam-resistant clones were selected in Luria Bertani agar (Unipath Ltd, Basingstoke, UK) supplemented with ampicillin (50 mg/l) plus chloramphenicol (20 mg/l). Susceptibility testing Susceptibility to various -lactam antibiotics and penicillininhibitor combinations was determined by an agar dilution assay according to the guidelines of the National Committee for Clinical Laboratory Standards (NCCLS). 20 Mueller Hinton agar (Unipath) containing the appropriate antibiotic concentrations was inoculated with 10 4 cfu/spot and incubated for 18 h at 37 C. The initial screening for clones producing mutant -lactamases was performed by a disc diffusion method. Antibiotic discs, -lactam antibiotics, clavulanate and sulbactam were purchased from commercial sources. Tazobactam was a gift from Wyeth Hellas S.A. Etest strips detecting the extended-spectrum -lactamases (ESBLs) (ceftazidime and ceftazidime clavulanate) were also used according to the instructions of the manufacturer (Biodisk, Solna, Sweden). PCR-based site-directed mutagenesis Mutant -lactamases were constructed by the megaprimer PCR-based site-directed mutagenesis method essentially as described previously. 19 A mutagenic and an external primer were used in the first round of PCR to create the megaprimer. In the second round of PCR, the megaprimer and an external primer were used. The resulting amplicons were digested with SmaI and ClaI and subcloned into pbcsk( ). The mutagenic primer (5 -TGGCCGAGCGAGATCAGCAAAT-3 ) was 22 nucleotides long and contained a single base mismatch close to the centre of the sequence in order to direct mutagenesis at codon 276 of the mature peptide (with GAT instead of AAT at codon 276). Oligonucleotide primers were prepared in an Applied Biosystems DNA synthesizer according to the instructions of the manufacturer (Applied Biosystems, Foster City, CA, USA). DNA sequencing was -Lactamase assays To obtain enzyme preparations containing the wild-type and mutant -lactamases, the respective E. coli DH5 clones were grown exponentially at 37 C for 18 h in tryptone soya broth (Unipath). Bacterial cells were harvested and washed twice in phosphate-buffered saline (ph 7.0). -Lactamases were released after mild ultrasonic treatment of cells suspended in phosphate buffer (PB, 100 mm, ph 7.0). The extracts were clarified by ultracentrifugation and dialysed overnight against PB. The protein content of the extracts was determined with a Bio-Rad Protein Assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Isoelectric focusing (IEF) was performed in polyacrylamide gels containing ampholytes which covered a ph range from 3.5 to 9.5 (Pharmacia-LKB Biotechnology, Uppsala, Sweden). -Lactamase bands were visualized with nitrocefin (Unipath). The -lactamase activity of the Table I. Plasmids used in the study Plasmid Characteristics Source or reference pbcsk( ) puc19-derived high-copy plasmid conferring resistance to chloramphenicol Stratagene a pan1 pbcsk( ) derivative containing a SmaI ClaI fragment encoding SHV-1 16 pan2 pan1 derivative encoding SHV-1(Asn276 Asp) mutant -lactamase This study pnf2 pbcsk( ) derivative containing a SmaI ClaI fragment encoding SHV-5 26 pan6 pnf2 derivative encoding SHV-5(Asn276 Asp) mutant -lactamase This study a Stratagene, La Jolla, CA, USA. 24
3 Asn276 Asp substitution in SHV -lactamases extracts was quantified using nitrocefin as substrate. Results were expressed as units of activity. One unit was the amount of enzyme hydrolysing 1 mol of substrate/ min/mg of protein at ph 7.0 and 37 C. Inhibition profiles were determined using clavulanate, tazobactam and sulbactam as described previously. 21 Nitrocefin was used as the reporter substrate at a concentration of 100 M. The amount of each -lactamase preparation was normalized to give 150 M nitrocefin hydrolysed per minute. The IC 50 values were determined by incubating the enzyme preparations with various concentrations of inhibitor for 5 min before the addition of nitrocefin. The maximum rates of hydrolysis of various -lactam substrates were determined by UV spectrophotometry (37 C, ph 7.0) as described previously 15 and expressed relative to that of nitrocefin, which was set at 100 (relative V max ). Results The susceptibility to -lactams of the E. coli clones producing either a wild-type or a mutant SHV -lactamase is presented in Table II. Units of activity for each crude enzyme preparation were as follows: SHV-1, 37.1 U; SHV- 1(Asn276 Asp), 30.5 U; SHV-5, 14.3 U; and SHV- 5(Asn276 Asp), 15.6 U. The inhibition and substrate profiles of SHV-1, SHV-5 and the mutant enzymes are shown in Tables III and IV respectively. The IEF experiments (Figure 1) showed that the mutant -lactamases were focused at a lower ph than the respective parental enzymes, as was expected from the replacement of the neutral asparagine by the negatively charged aspartic acid. Effect of Asn276 Asp on SHV-1 The clone producing SHV-1(Asn276 Asp) was slightly less resistant to amoxycillin, ticarcillin and piperacillin than the clone producing the SHV-1 -lactamase. In contrast, the mutant enzyme, compared with SHV-1, conferred higher levels of resistance to penicillin-inhibitor combinations. Cephalothin and cefprozil were four-fold more active Table III. Inhibition profiles of SHV-1, SHV-5 and the respective mutant -lactamases; the values in parentheses show the fold increase of IC 50 values of each inhibitor caused by the replacement of Asn276 by Asp IC 50 ( M) of inhibitor -Lactamase clavulanate tazobactam sulbactam SHV-1 wild type Asn276 Asp 0.53 (8.8) 1.13 (8.0) 20 SHV-5 wild type Asn276 Asp 0.20 (10.0) 0.42 (5.2) 3.18 (1.8) Table II. Susceptibility to -lactam antibiotics of E. coli DH5 clones expressing SHV-1, SHV-5 and the respective Asn276 Asp mutant -lactamases MIC (mg/l) for E. coli clones producing: Antibiotic SHV-1 Asn276 Asp SHV-5 Asn276 Asp DH5 Amoxycillin Ticarcillin Piperacillin Amoxycillin clavulanate a Ticarcillin clavulanate a Piperacillin tazobactam b Cephalothin Cefprozil Cefotaxime Ceftriaxone Ceftazidime Ceftazidime clavulanate b ND c ND Aztreonam Cefpirome Cefepime a Inhibitor concentration fixed at 2 mg/l. b Inhibitor concentration fixed at 4 mg/l. c Not determined. 25
4 P. Giakkoupi et al. Table IV. Maximum hydrolysis rates of -lactam antibiotics. The values are relative to the hydrolysis rate of nitrocefin which was set at 100. The percentage changes in relative hydrolysis rates are in parentheses Relative V max a SHV-1 SHV-5 -Lactam wild type Asn276 Asp wild type Asn276 Asp Nitrocefin Penicillin G ( 37%) ( 23%) Cephalothin ( 42%) ( 39%) Cefotaxime ND b ND ( 44%) Cefepime ( 62%) ( 44%) a The values are the means of three determinations not differing by 10%. b Not determined. Hydrolysis rates were too low. Figure 1. Isoelectric focusing of SHV-1, SHV-1(Asn276 Asp), SHV-5 and SHV-5 (Asn276 Asp) -lactamases (lanes 1 4, respectively). A preparation of SHV- -lactamase-free E. coli DH5 cells is in lane 5. -Lactamases with known pis (PSE-2, pi 6.1; SHV-1, pi 7.6; SHV-5, pi 8.2 and LAT-1) are in lane 6. against the isogenic clone that expressed the SHV-1 (Asn276 Asp) mutant -lactamase. Compared with the SHV-1-producing E. coli clone, its SHV-1(Asn276 Asp)- producing counterpart was found to be more susceptible to all third-generation oxyimino- -lactams tested, except ceftazidime. The MICs of the latter antibiotic remained unaltered. Notably, the MICs of cefpirome and cefepime were consistently one- to two-dilutions higher in the E. coli clone producing the SHV-1(Asn276 Asp) mutant - lactamase (Table II). As is shown in Table III, Asn276 Asp substitution rendered the SHV-1 -lactamase less susceptible to mechanism-based inhibitors, increasing the IC 50 values of clavulanic acid and tazobactam by a factor of 8.8 and 8.0 respectively. The IC 50 of sulbactam, when tested against SHV-1(Asn276 Asp), was 20 M and higher concentrations of this inhibitor were not used. The relative maximum hydrolysis rates are presented in Table IV. The results for cephalothin and cefepime were in line with the differences observed in the isogenic MIC determinations; the Asn276 Asp mutant enzyme hydrolysed cefepime more rapidly and cephalothin more slowly than the SHV-1 -lactamase. Despite the evident decrease in efficiency against penicillins (Table II), the mutant -lactamase hydrolysed penicillin G more quickly than the parental enzyme. Effect of Asn276 Asp on SHV-5 Like the pair of clones described above, the E. coli strain expressing the SHV-5(Asn276 Asp) mutant enzyme was less resistant to penicillins, cephalothin and cefprozil than its SHV-5-producing isogenic counterpart. The MICs of penicillin-inhibitor combinations were higher for the SHV- 5(Asn276 Asp)-producing clone than for the strain expressing the SHV-5 ESBL. The most noticeable effect of 26
5 (a) (b) Figure 2. Application of ESBL-detecting Etest in the E. coli strains producing (a) wild-type and (b) Asn276 Asp mutant SHV -lactamases. The upper side of the strip contained ceftazidime; the lower side contained ceftazidime plus a fixed concentration (4 mg/l) of clavulanate. the Asn276 Asp replacement on the resistance phenotype conferred by SHV-5 was the drastic reduction of activity against cefotaxime and ceftriaxone. The MICs of ceftazidime and aztreonam were virtually unaltered. The combination of ceftazidime with clavulanate was active against the SHV-5-producing E. coli strain. The clone expressing the SHV-5(Asn276 Asp) mutant -lactamase was less susceptible to the latter combination (Table II and Figure 2). As can also be seen in Figure 2, the SHV- 5(Asn276 Asp) mutant did not seem to be an ESBL according to the requirements of this particular Etestbased method. Cefpirome and cefepime were slightly less active against the clone that produced the mutant SHV-5 (Table II). The concentrations of clavulanate, tazobactam and sulbactam required for a 50% reduction (IC 50 ) of the rate of nitrocefin hydrolysis by SHV-5(Asn276 Asp) were 10.0-, 5.2- and 1.8-fold higher than those for SHV-5 - lactamase (Table III). SHV-5(Asn276 Asp) hydrolysed penicillin G and cefepime more quickly and cefotaxime more slowly than the SHV-5 -lactamase. Although the mutant -lactamase conferred a lower level of resistance to cephalothin than did SHV-5 (Table II), the antibiotic was hydrolysed more quickly by the former enzyme (Table IV). Discussion Class A -lactamases all interact with -lactams in a similar mode: a well ordered network of hydrogen bonds and electrostatic interactions aligns the substrate within the active site, facilitating a nucleophilic attack against the -lactam ring by Ser70, and the release of the inactivated product. 22 Asparagine at position 276 is not conserved among class A enzymes, but is present in both TEM and SHV -lactamases, which have extensive homology (67%). 23 Previous studies with TEM-1 indicated that Asn276 cannot be substituted by most amino acids, including aspartic acid, without a marked decrease in hydrolytic activity. 17 -Lactam susceptibility testing using isogenic systems can demonstrate differences in hydrolytic efficiencies of related -lactamases. 24,25 The MICs of E. coli clones producing SHV-1, SHV-5 and their respective Asn276 Asp mutants were determined under isogenic conditions. Therefore, the observed changes in the MICs of the -lactams and -lactam-inhibitor combinations suggested that replacement of Asn276 by aspartic acid conferred resistance to -lactamase inhibitors and influenced the hydrolytic efficiencies of SHV-1 and SHV-5 -lactamases. Asn276 is on the C-terminal -helix and its side-chain lies far from the active site of TEM and SHV enzymes. The carbonyl group of Asn276 accepts two hydrogen bonds from Arg244 and this bonding contributes to the proper orientation of the guanidium group of Arg The latter positively charged group is critical for -lactam binding, and for inactivation by suicide inhibitors: one of its NH 2 groups forms a hydrogen bond with the C-3 (C-4) -lactam carboxylate, and the second more exposed amino group holds in place a water molecule (W673) which participates in the process of irreversible inactivation by clavulanate. 22 In TEM-1(Asn276 Asp), Asp276 may form a salt bridge with Arg244, 17 leading to a slight change in the orientation of the guanidium group and altering the position of W673. Such alterations in the active site cavity may explain why SHV-1(Asn276 Asp) and SHV-5(Asn276 Asp) were less susceptible to inhibitors than were the parental -lactamases. As shown by the MIC determinations, the net result 27
6 P. Giakkoupi et al. of the Asn276 Asp substitution in SHV-1 and SHV-5 -lactamases was to reduce hydrolytic activity against most -lactams. As mentioned above, Arg244 is involved mainly in substrate binding. Assuming that the consequence of Asn276 Asp mutation is to alter the position of the Arg244 side-chain, this reduction resulted from lower enzyme substrate affinity. Replacement of Asn276 by Asp caused diverse changes in the substrate profiles of SHV-1 and SHV-5 (Table IV). An increase in the hydrolysis rates of some -lactams has been observed with the analogous mutant -lactamases TEM-1(Asn276 A s p ) 17 and OHIO-1 (Asn276 Gly), 18 while the respective catalytic efficiencies were lower than those of the parental -lactamases. Such discrepancies underline the different interactions of each particular -lactamase with different -lactams, and the differences in the active site of an ESBL with that of its parental penicillinase. Interestingly, the replacement of Asn276 by Asp improved the ability of SHV-1 and SHV-5 to inactivate the fourth-generation cephalosporins cefpirome and cefepime. The presence of aspartic acid at position 276 leads to a decrease in the positive potential of the active site, 22 and thus may facilitate electrostatically the docking of the latter antibiotics, which possess a positively charged quaternary ammonium group at C-3. Several recent studies have reported the emergence of inhibitor-resistant TEM-1/TEM-2 -lactamase variants. In some areas (e.g. Clermont-Ferrand, France), these enzymes appear at a relatively high frequency among enterobacteria. 6 8 Analogous inhibitor-resistant SHV variants have not been described. The inhibitor-resistant SHV-10 has been derived from an SHV-5 variant by replacement of Ser130 by Gly. 26 TEM-1/TEM-2 - l a c t a m- ases occur more frequently than SHV-1 among enterobacteria (reviewed in references 27 and 28). Therefore the possibility of selection of inhibitor-resistant SHV variants is expected to be lower. Furthermore, the emergence of some of these mutants, e.g. SHV-1(Asn276 Asp), could pass unnoticed in routine susceptibility tests. The above hypotheses may explain partly the apparent absence of inhibitor-resistant SHV -lactamases. Acknowledgements We thank Dr H. Hachler for providing plasmids encoding SHV -lactamases. We also thank Drs V. Miriagou and C. A. Owen for helpful suggestions. References 1. Sutherland, R. (1995). -Lactam/ -lactamase inhibitor combinations: development, antibacterial activity and clinical applications. Infection 23, Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for -lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, Blazquez, J., Baquero, M.-R., Canton, R., Alos, I. & Baquero, F. (1993). Characterization of a new TEM-type -lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrobial Agents and Chemotherapy 37, Brun, T., Peduzzi, J., Canica, M. M., Paul, G., Nevot, P., Barthelemy, M. et al. (1994). Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to -lactamase inhibitors. FEMS Microbiology Letters 120, Canica, M. M., Barthelemy, M., Gilly, L., Labia, R., Krishnamoorthy, R. & Paul, G. (1997). Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type -lactamases. Antimicrobial Agents and Chemotherapy 41, Stapleton, P., Wu, P. J., King, A., Shannon, K., French, G. & Phillips, I. (1995). Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrobial Agents and Chemotherapy 39, Zhou, X. Y., Bordon, F., Sirot, D., Kitzis, M. D. & Gutmann, L. (1994). Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 -lactamase conferring resistance to -lactamase inhibitors. AntimicrobialAgents and Chemotherapy 38, Henquell, C., Chanal, C., Sirot, D., Labia, R. & Sirot, J. (1995). Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM -lactamases from clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy 39, Vedel, G., Belaaouaj, A., Gilly, L., Labia, R., Philippon, A., Nevot, P. et al. (1992). Clinical isolates of Escherichia coli producing TRI -lactamases: novel TEM-enzymes conferring resistance to - lactamase inhibitors. Journal of Antimicrobial Chemotherapy 30, Lemozy, J., Sirot, D., Chanal, C., Huc, C., Labia, R., Dabernat, H. et al. (1995). First characterization of inhibitor-resistant TEM (IRT) -lactamases in Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy 33, Bret, L., Chanal, C., Sirot, D., Labia, R. & Sirot, J. (1996). Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 -lactamase produced by Proteus mirabilis strains. Journal of Antimicrobial Chemotherapy 38, Belaaouaj, A., Lapoumeroulie, C., Canica, M. M., Vedel, G., Nevot, P., Krishnamoorthy, R. et al. (1994). Nucleotide sequence of the genes coding for the TEM-like -lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiology Letters 120, Ambler, R. P., Coulson, A. F. W., Frere, J.-M., Ghuysen, J. M., Joris, B., Forsman, M. et al. (1991). A standard numbering scheme for the class A -lactamases. Biochemical Journal 276, Bonomo, R. A., Currie-McCumber, C. & Shlaes, D. M. (1992). OHIO-1 -lactamase resistant to mechanism-based inactivators. FEMS Microbiology Letters 71, Giakkoupi, P., Miriagou, V., Gazouli, M., Tzelepi, E., Legakis, N. J. & Tzouvelekis, L. S. (1998). Properties of mutant SHV-5 - lactamases constructed by substitution of isoleucine or valine for methionine at position 69. Antimicrobial Agents and Chemotherapy 42, Giakkoupi, P., Tzelepi, E., Legakis, N. J. & Tzouvelekis, L. S. (1998). Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 28
7 Asn276 Asp substitution in SHV -lactamases -lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes. FEMS Microbiology Letters 160, Saves, I., Burlet-Schiltz, O., Swaren, P., Lefevre, F., Masson, J.-M., Prome, J.-C. et al. (1995). The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the -lactamase resistance to clavulanic acid. Journal of Biological Chemistry 270, Bonomo, R. A., Dawes, C. G., Knox, J. R. & Shlaes, D. M. (1995). -Lactamase mutations far from the active site influence inhibitor binding. Biochimica et Biophysica Acta 1247, Smith, K. D., Valenzuela, A., Vigna, J. L., Aalbers, K. & Lutz, C. T. (1993). Unwanted mutations in PCR mutagenesis: avoiding the predictable. PCR Methods and Applications 2, National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically Second Edition: Approved Standard M7-A3. NCCLS, Villanova, PA. 21. Tzouvelekis, L. S., Gazouli, M., Prinarakis, E. E., Tzelepi, E. & Legakis N. J. (1997). Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro against -lactamases that belong to groups 1, 2b and 2be. Antimicrobial Agents and Chemotherapy 41, Matagne, A., Lamotte-Brasseur, J. & Frere, J.-M. (1998). Catalytic properties of class A -lactamases: efficiency and diversity. Biochemical Journal 330, Knox, J. R. (1995). Extended-spectrum and inhibitor-resistant TEM-type -lactamases: mutations, specificity, and threedimensional structure. Antimicrobial Agents and Chemotherapy 39, Blazquez, J., Morosini, M.-I., Negri, M.-C., Gonzalez-Leiza, M. & Baquero, F. (1995). Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM -lactamases. Antimicrobial Agents and Chemotherapy 39, Nuesch-Inderbinen, M. T., Hachler, H. & Kayser, F. H. (1995). New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV -lactamases. Antimicrobial Agents and Chemotherapy 39, Prinarakis, E. E., Miriagou, V., Tzelepi, E., Gazouli, M. & Tzouvelekis, L. S. (1997). Emergence of an inhibitor-resistant -lactamase (SHV-10) derived from an SHV-5 variant. Antimicrobial Agents and Chemotherapy 41, Du Bois, S. K., Marriott, M. S. & Amyes, S. G. B. (1995). TEMand SHV-derived extended-spectrum -lactamases: relationship between selection, structure and function. Journal of Antimicrobial Chemotherapy 35, Livermore, D. M. (1995). -Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, Received 20 May 1998; returned 9 July 1998; revised 3 August 1998; accepted 17 August
8
FEMS Microbiology Letters 160 (1998) 49^54. Received 27 December 1997; accepted 2 January 1998
FEMS Microbiology Letters 160 (1998) 49^54 Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 L-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic e ciency of the enzymes
More informationSelection and Characterization of -Lactam -Lactamase Inactivator- Resistant Mutants following PCR Mutagenesis of the TEM-1 -Lactamase Gene
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1998, p. 1542 1548 Vol. 42, No. 7 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Selection and Characterization
More informationReviews. Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Journal of Antimicrobial Chemotherapy (1999) 43, 447 458 Reviews JAC Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics E. B. Chaïbi a, D. Sirot b, G. Paul c and R.
More informationThe GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity
Promega Notes Magazine Number 62, 1997, p. 02 The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity By Christine Andrews and Scott Lesley Promega
More informationTransferable Cefoxitin Resistance in Enterobacteria from Greek Hospitals and Characterization of a Plasmid-Mediated Group 1 -Lactamase (LAT-2)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1996, p. 1736 1740 Vol. 40, No. 7 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Transferable Cefoxitin Resistance in Enterobacteria
More informationDiscriminatory Detection of Inhibitor-Resistant -Lactamases in Escherichia coli by Single-Strand Conformation Polymorphism-PCR
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1998, p. 879 884 Vol. 42, No. 4 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Discriminatory Detection of Inhibitor-Resistant -Lactamases
More informationThe Role of Residue 238 of TEM-1 -Lactamase in the Hydrolysis of Extended-spectrum Antibiotics*
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 41, Issue of Octobere 9, pp. 26603 26609, 1998 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The Role of
More informationExtended-Spectrum -Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2001, p. 933 951 Vol. 14, No. 4 0893-8512/01/$04.00 0 DOI: 10.1128/CMR.14.4.933 951.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Extended-Spectrum
More informationVariable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases
Journal of Antimicrobial Chemotherapy (2003) 51, 605 612 DOI: 10.1093/jac/dkg114 Advance Access publication 28 January 2003 Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with
More informationSequences of -Lactamase Genes Encoding CTX-M-1 (MEN-1) and CTX-M-2 and Relationship of Their Amino Acid Sequences with Those of Other -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1996, p. 509 513 Vol. 40, No. 2 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Sequences of -Lactamase Genes Encoding CTX-M-1 (MEN-1)
More informationinhibitors, clavulanate, inhibitor-resistant b-lactamases, IRT, review
REVIEW IRT and CMT b-lactamases and inhibitor resistance R. Cantón 1,2, M. I. Morosini 1,2, O. Martin 1,2, S. de la Maza 1,2 and E. Gomez G. de la Pedrosa 1,2 1 Servicio de Microbiología, Hospital Universitario
More informationExperimental Prediction of the Natural Evolution of Antibiotic Resistance
Copyright 2003 by the Genetics Society of America Experimental Prediction of the Natural Evolution of Antibiotic Resistance Miriam Barlow and Barry G. Hall 1 Biology Department, University of Rochester,
More informationSUMMARY. Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M,
SUMMARY Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M, The doctoral thesis entitled Prevalence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBL) isolated from broilers
More information-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2002, p. 3156 3163 Vol. 46, No. 10 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.10.3156 3163.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationReceived 22 August 2006/Returned for modification 26 October 2006/Accepted 2 January 2007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2007, p. 1304 1309 Vol. 51, No. 4 0066-4804/07/$08.00 0 doi:10.1128/aac.01058-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Evolution
More informationExtended Spectrum β-lactamases: Critical Tools of Bacterial Resistance
Review Article Mahidol University Journal of Pharmaceutical Science 2012; 39 (1), 1-8 Extended Spectrum β-lactamases: Critical Tools of Bacterial Resistance Department of Microbiology, Faculty of Pharmacy,
More informationIncidence and Mechanisms of Resistance to the Combination of Amoxicillin and Clavulanic Acid in Escherichia coli
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1995, p. 2478 2483 Vol. 39, No. 11 0066-4804/95/$04.00 0 Incidence and Mechanisms of Resistance to the Combination of Amoxicillin and Clavulanic Acid in Escherichia
More informationBeta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology,
More informationReceived 14 November 2001/Returned for modification 16 March 2002/Accepted 26 July 2002
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2002, p. 3971 3977 Vol. 46, No. 12 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.12.3971 3977.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationOngoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
Journal of Antimicrobial Chemotherapy (2008) 61, 59 63 doi:10.1093/jac/dkm443 Advance Access publication 13 November 2007 Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece:
More informationPrevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype
J Antimicrob Chemother 2010; 65: 460 464 doi:10.1093/jac/dkp484 Advance publication 22 January 2010 Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC
More informationBasic concepts of molecular biology
Basic concepts of molecular biology Gabriella Trucco Email: gabriella.trucco@unimi.it Life The main actors in the chemistry of life are molecules called proteins nucleic acids Proteins: many different
More informationSHV-1 -Lactamase Is Mainly a Chromosomally Encoded Species-Specific Enzyme in Klebsiella pneumoniae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2001, p. 2856 2861 Vol. 45, No. 10 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.10.2856 2861.2001 Copyright 2001, American Society for Microbiology. All Rights
More informationInfectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon,
AAC Accepts, published online ahead of print on 14 November 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01444-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationUse of Bioinformatics to Investigate β-lactamase, a Mediator of β-lactam Antibiotic Resistance
Use of Bioinformatics to Investigate β-lactamase, a Mediator of β-lactam Antibiotic Resistance Paula Lessem Director of Biological Sciences University of Richmond Biology Department Richmond, VA 23173
More informationConstruction of a Mutant pbr322 Using Site-Directed Mutagenesis to Investigate the Exclusion Effects of pbr322 During Co-transformation with puc19
Construction of a Mutant pbr322 Using Site-Directed Mutagenesis to Investigate the Exclusion Effects of pbr322 During Co-transformation with puc19 IVANA KOMLJENOVIC Department of Microbiology and Immunology,
More informationAn extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection
FEMS Microbiology Letters 165 (1998) 85^90 An extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection Mar èa-isabel Morosini a, Mar èa-cristina Negri a, Brian Shoichet b, Mar
More informationHetero-Stagger PCR Cloning Kit
Product Name: Code No: Size: DynaExpress Hetero-Stagger PCR Cloning Kit DS150 20 reactions Kit Components: Box 1 (-20 ) phst-1 Vector, linearized Annealing Buffer Ligase Mixture phst Forward Sequence Primer
More informationTEM-80, a Novel Inhibitor-Resistant -Lactamase in a Clinical Isolate of Enterobacter cloacae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2002, p. 1183 1189 Vol. 46, No. 5 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.5.1183 1189.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationJAC A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa
Journal of Antimicrobial Chemotherapy (2002) 49, 561 565 JAC A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa Laurent Poirel a,
More informationUnderstanding the Cellular Mechanism of the Excess Microsporocytes I (EMSI) Gene. Andrew ElBardissi, The Pennsylvania State University
Understanding the Cellular Mechanism of the Excess Microsporocytes I (EMSI) Gene Andrew ElBardissi, The Pennsylvania State University Abstract: Hong Ma, The Pennsylvania State University The Excess Microsporocytes
More informationContribution of Natural Amino Acid Substitutions in SHV Extended-Spectrum -Lactamases to Resistance against Various -Lactams
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2000, p. 2759 2763 Vol. 44, No. 10 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Contribution of Natural Amino
More informationREVIEW ARTICLE Catalytic properties of class A β-lactamases: efficiency and diversity
Biochem. J. (1998) 330, 581 598 (Printed in Great Britain) 581 REVIEW ARTICLE Catalytic properties of class A β-lactamases: efficiency and diversity Andre MATAGNE 1, Josette LAMOTTE-BRASSEUR and Jean-Marie
More information7.1 Techniques for Producing and Analyzing DNA. SBI4U Ms. Ho-Lau
7.1 Techniques for Producing and Analyzing DNA SBI4U Ms. Ho-Lau What is Biotechnology? From Merriam-Webster: the manipulation of living organisms or their components to produce useful usually commercial
More informationSome types of Mutagenesis
Mutagenesis What Is a Mutation? Genetic information is encoded by the sequence of the nucleotide bases in DNA of the gene. The four nucleotides are: adenine (A), thymine (T), guanine (G), and cytosine
More informationReal-Time PCR and Melting Curve Analysis for Reliable and Rapid Detection of SHV Extended-Spectrum -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p. 1730 1736 Vol. 45, No. 6 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.6.1730 1736.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationReal-Time PCR and Melting Curve Analysis for Reliable and Rapid Detection of SHV Extended-Spectrum -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p. 1730 1736 Vol. 45, No. 6 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.6.1730 1736.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationAbstract. Introduction
ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02893.x Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin clavulanate and piperacillin tazobactam with extended-spectrum
More informationResistance, Yonsei University College of Medicine, Seoul, Korea; and 2 Department of
AAC Accepts, published online ahead of print on March 0 Antimicrob. Agents Chemother. doi:./aac.0- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationThe biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush
International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.
More informationPrevalence of -Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2000, p. 1930 1935 Vol. 44, No. 7 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Prevalence of -Lactamases among
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationACCEPTED. Variant CTX-M-59 in a Neonatal Intensive Care Unit in. Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh,
AAC Accepts, published online ahead of print on 1 March 00 Antimicrob. Agents Chemother. doi:./aac.0-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationReceived 4 December 1996/Returned for modification 17 March 1997/Accepted 21 May 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1997, p. 2191 2197 Vol. 35, No. 9 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Screening Methods for Detection of Extended-
More informationDetection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli
ISSN: 2319-7706 Volume 2 Number 8 (2013) pp. 196-205 http://www.ijcmas.com Original Research Article Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia
More informationH. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu
Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province,
More informationReceived 6 July 2004; returned 14 August 2004; revised 6 September 2004; accepted 8 September 2004
Journal of Antimicrobial Chemotherapy (2004) 54, 870 875 DOI: 10.1093/jac/dkh449 Advance Access publication 7 October 2004 Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum
More informationAmpicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different -Lactam Resistance Phenotypes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1999, p. 862 867 Vol. 43, No. 4 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Ampicillin-Sulbactam and Amoxicillin-Clavulanate
More informationAmpicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different -Lactam Resistance Phenotypes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1999, p. 862 867 Vol. 43, No. 4 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Ampicillin-Sulbactam and Amoxicillin-Clavulanate
More informationChapter VI: Mutagenesis to Restore Chimera Function
99 Chapter VI: Mutagenesis to Restore Chimera Function Introduction Identifying characteristics of functional and nonfunctional chimeras is one way to address the underlying reasons for why chimeric proteins
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationProblem Set 8. Answer Key
MCB 102 University of California, Berkeley August 11, 2009 Isabelle Philipp Online Document Problem Set 8 Answer Key 1. The Genetic Code (a) Are all amino acids encoded by the same number of codons? no
More informationComparative Characterization of the Cephamycinase bla CMY-1 Gene and Its Relationship with Other -Lactamase Genes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1996, p. 1926 1930 Vol. 40, No. 8 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Comparative Characterization of the Cephamycinase bla
More informationStep 1: Digest vector with Reason for Step 1. Step 2: Digest T4 genomic DNA with Reason for Step 2: Step 3: Reason for Step 3:
Biol/Chem 475 Spring 2007 Study Problems for Quiz 2 Quiz 2 (~50 pts) is scheduled for Monday May 14 It will cover all handouts and lab exercises to date except the handout/worksheet (yet to be distributed)
More informationSupplementary Figure 1
Supplementary Figure 1 2 Supplementary Figure 1: Sequence alignment of HsHSD17B8 and HsCBR4 of with KAR orthologs. The secondary structure elements as calculated by DSSP and residue numbers are displayed
More informationEffect of D240G substitution in a novel ESBL CTX-M-27
Advance Access published May 29, 2003 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkg256 Effect of D240G substitution in a novel ESBL CTX-M-27 R. Bonnet 1 *, C. Recule 2, R. Baraduc 1, C. Chanal
More informationAntimicrobial and Antibacterial Agents
Antimicrobial and Antibacterial Agents Contents Introduction Classification of antimicrobial drugs Special terms Mechanism of action Resistance of antimicrobial agent Introduction Joseph Lister 1867 -
More informationA Novel Class C -Lactamase (FOX-2) in Escherichia coli Conferring Resistance to Cephamycins
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1997, p. 2041 2046 Vol. 41, No. 9 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology A Novel Class C -Lactamase (FOX-2) in Escherichia
More informationBasic concepts of molecular biology
Basic concepts of molecular biology Gabriella Trucco Email: gabriella.trucco@unimi.it What is life made of? 1665: Robert Hooke discovered that organisms are composed of individual compartments called cells
More informationSupplementary Online Material. An Expanded Eukaryotic Genetic Code 2QH, UK. * To whom correspondence should be addressed.
Supplementary Online Material An Expanded Eukaryotic Genetic Code Jason W. Chin 1, T. Ashton Cropp, J. Christopher Anderson, Mridul Mukherji, Zhiwen Zhang and Peter G. Schultz* Department of Chemistry
More informationOXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan
OXA-type J Microbiol ESBLs Immunol in P. Infect aeruginosa 2006;39:130-134 OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital
More informationRussian Klebsiella pneumoniae isolates that express extended-spectrum b-lactamases
Concise Communications 103 Russian Klebsiella pneumoniae isolates that express extended-spectrum b-lactamases P. L. Winokur 1,2,3 *, M. V. Eidelstain 4, O. Stetsiouk 4, L. Stratchounski 4, J. Blahova 5,
More informationZool 3200: Cell Biology Exam 3 3/6/15
Name: Trask Zool 3200: Cell Biology Exam 3 3/6/15 Answer each of the following questions in the space provided; circle the correct answer or answers for each multiple choice question and circle either
More informationAlgorithms in Bioinformatics ONE Transcription Translation
Algorithms in Bioinformatics ONE Transcription Translation Sami Khuri Department of Computer Science San José State University sami.khuri@sjsu.edu Biology Review DNA RNA Proteins Central Dogma Transcription
More informationCharacterization of bla CMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli
Journal of Antimicrobial Chemotherapy (2002) 49, 269 273 Characterization of bla CMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli Sang Hee Lee a *,
More informationHighly efficient one-step PCR-based mutagenesis technique for large plasmids using high-fidelity DNA polymerase
Highly efficient one-step PCR-based mutagenesis technique for large plasmids using high-fidelity DNA polymerase H. Liu, R. Ye and Y.Y. Wang Department of Medical Microbiology and Parasitology, School of
More informationTHE USE OF SEKISUI DIAGNOSTICS PENICILLINASE
THE USE OF SEKISUI DIAGNOSTICS PENICILLINASE AND β-lactamase PRODUCTS INTRODUCTION The aim of this guide is to outline the general procedures for the use of Sekisui Diagnostics Penicillinase and β-lactamase
More informationBacterial Genetics. Stijn van der Veen
Bacterial Genetics Stijn van der Veen Differentiating bacterial species Morphology (shape) Composition (cell envelope and other structures) Metabolism & growth characteristics Genetics Differentiating
More informationINTRODUCTION METHODS Printed in Great Britain. Correspondence Mark A. Fisher
Journal of Medical Microbiology (2009), 58, 774 778 DOI 10.1099/jmm.0.006171-0 Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum
More informationExam 2 Key - Spring 2008 A#: Please see us if you have any questions!
Page 1 of 5 Exam 2 Key - Spring 2008 A#: Please see us if you have any questions! 1. A mutation in which parts of two nonhomologous chromosomes change places is called a(n) A. translocation. B. transition.
More informationMolecular methods for detection of Antibiotic Resistance in environmental matrices: limits, prospects and challenges.
Dr. Angela Cicatelli acicatelli@unisa.it Molecular methods for detection of Antibiotic Resistance in environmental matrices: limits, prospects and challenges. 1st Workshop on "Risk prognosis of environmental
More informationJournal of Experimental Microbiology and Immunology (JEMI) Vol. 6:20-25 Copyright December 2004, M&I UBC
Preparing Plasmid Constructs to Investigate the Characteristics of Thiol Reductase and Flavin Reductase With Regard to Solubilizing Insoluble Proteinase Inhibitor 2 in Bacterial Protein Overexpression
More informationpsg5 Vector INSTRUCTION MANUAL Catalog # Revision A For In Vitro Use Only
psg5 Vector INSTRUCTION MANUAL Catalog #216201 Revision A For In Vitro Use Only 216201-12 LIMITED PRODUCT WARRANTY This warranty limits our liability to replacement of this product. No other warranties
More informationKrzysztof Sieradzki and Alexander Tomasz* The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 47 51 JAC Suppression of -lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell
More information7.014 Quiz II Handout
7.014 Quiz II Handout Quiz II: Wednesday, March 17 12:05-12:55 54-100 **This will be a closed book exam** Quiz Review Session: Friday, March 12 7:00-9:00 pm room 54-100 Open Tutoring Session: Tuesday,
More informationAntibiotics. Disks for agar diffusion tests were purchased from Diagnostics Pasteur. Antibiotic powders were provided
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1988, p. 1660-1665 0066-4804/88/111660-06$02.00/0 Copyright X 1988, American Society for Microbiology Vol. 32, No. 11 Comparative Study of a Novel Plasmid-Mediated
More information7.014 Problem Set 4 Answers to this problem set are to be turned in. Problem sets will not be accepted late. Solutions will be posted on the web.
MIT Department of Biology 7.014 Introductory Biology, Spring 2005 Name: Section : 7.014 Problem Set 4 Answers to this problem set are to be turned in. Problem sets will not be accepted late. Solutions
More informationpgm-t Cloning Kit Cat. # : GVT202 Size : 20 Reactions Store at -20
pgm-t Cloning Kit Cat. # : GVT202 Size : 20 Reactions Store at -20 1 Kit Contents Contents pgm-t Cloning Kit pgm-t Vector (50 ng/μl) 20 μl T4 DNA Ligase (3 U/μl) 20 μl 10X T4 DNA Ligation Buffer 30 μl
More informationSupplementary Information
Supplementary Information Supplementary Figures Figure S1. Study of mgtl translation in vitro. (A) Detection of 5 LR RNA using wild-type and anti-sd (91-95) substituted templates in a transcription-translation
More informationSusceptibility Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 213-217 Vol. 16, No. 2 0095-1137/82/080213-05$02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L.
More informationThe American University in Cairo
The American University in Cairo School of Science and Engineering MOLECULAR CHARACTERIZATION OF EXTENDED- SPECTRUM Beta LACTAMASE (ESBL) PRODUCING Klebsiella pneumoniae AND Escherichia coli AMONG HOSPITALIZED
More informationBioinformation Volume 5 open access
Molecular docking analysis of new generation cephalosporins interactions with recently known SHV-variants Asad Ullah Khan 1 *, Mohd Hassan Baig 1, Gulshan Wadhwa 2 1 Interdisciplinary Biotechnology Unit,
More information7.014 Solution Set 4
7.014 Solution Set 4 Question 1 Shown below is a fragment of the sequence of a hypothetical bacterial gene. This gene encodes production of HWDWN, protein essential for metabolizing sugar yummose. The
More informationIdentification and phylogenetic analysis of TEM gene from soil isolates
660 Journal of Scientific & Industrial Research J SCI IND RES VOL 66 AUGUST 2007 Vol. 66, August 2007, pp.660-666 Identification and phylogenetic analysis of TEM gene from soil isolates Sudheer Kumar Singh,
More informationRegulation of enzyme synthesis
Regulation of enzyme synthesis The lac operon is an example of an inducible operon - it is normally off, but when a molecule called an inducer is present, the operon turns on. The trp operon is an example
More informationDetection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India
Detection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India Dr. Samiran Bandyopadhyay Scientist Indian Veterinary Research Institute Eastern
More informationConstruction of Glycine Oxidase Mutant Libraries by Random Mutagenesis, Site Directed Mutagenesis and DNA Shuffling Tao Zhan1, 2*
Construction of Glycine Oxidase Mutant Libraries by Random Mutagenesis, Site Directed Mutagenesis and DNA Shuffling Tao Zhan1, 2* 1 Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences,
More informationProblem: The GC base pairs are more stable than AT base pairs. Why? 5. Triple-stranded DNA was first observed in 1957. Scientists later discovered that the formation of triplestranded DNA involves a type
More informationSolutions to 7.02 Quiz II 10/27/05
Solutions to 7.02 Quiz II 10/27/05 Class Average = 83 Standard Deviation = 9 Range Grade % 87-100 A 43 74-86 B 39 55-73 C 17 > 54 D 1 Question 1 (56 points) While studying deep sea bacteria, you discover
More informationCharacterization of the Extended-Spectrum -Lactamase Reference Strain, Klebsiella pneumoniae K6 (ATCC ), Which Produces the Novel Enzyme SHV-18
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2000, p. 2382 2388 Vol. 44, No. 9 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Characterization of the Extended-Spectrum
More informationYour first goal is to determine the order of assembly of the 3 DNA polymerases during initiation.
MIT Department of Biology 7.28, Spring 2005 - Molecular Biology 1 Question 1 You are studying the mechanism of DNA polymerase loading at eukaryotic DNA replication origins. Unlike the situation in bacteria,
More information4/3/2013. DNA Synthesis Replication of Bacterial DNA Replication of Bacterial DNA
4/3/03 3 4 5 6 7 8 9 0 Chapter 8 Microbial Genetics Terminology Genetics: The study of what genes are, how they carry information, how information is expressed, and how genes are replicated Gene: A segment
More informationBIO303, Genetics Study Guide II for Spring 2007 Semester
BIO303, Genetics Study Guide II for Spring 2007 Semester 1 Questions from F05 1. Tryptophan (Trp) is encoded by the codon UGG. Suppose that a cell was treated with high levels of 5- Bromouracil such that
More informationCombinatorial Evolution of Enzymes and Synthetic pathways Using
Supplementary data Combinatorial Evolution of Enzymes and Synthetic pathways Using One-Step PCR Peng Jin,, Zhen Kang,,, *, Junli Zhang,, Linpei Zhang,, Guocheng Du,, and Jian Chen, The Key Laboratory of
More informationSupplementary Note 1. Enzymatic properties of the purified Syn BVR
Supplementary Note 1. Enzymatic properties of the purified Syn BVR The expression vector pet15b-syn bvr allowed us to routinely prepare 15 mg of electrophoretically homogenous Syn BVR from 2.5 L of TB-medium
More informationA Novel CTX-M -Lactamase (CTX-M-8) in Cefotaxime-Resistant Enterobacteriaceae Isolated in Brazil
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2000, p. 1936 1942 Vol. 44, No. 7 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. A Novel CTX-M -Lactamase (CTX-M-8)
More informationChapter 14 Regulation of Transcription
Chapter 14 Regulation of Transcription Cis-acting sequences Distance-independent cis-acting elements Dissecting regulatory elements Transcription factors Overview transcriptional regulation Transcription
More informationModule Code: BIO00007C
Examination Candidate Number: Desk Number: BSc and MSc Degree Examinations 2018-9 Department : BIOLOGY Title of Exam: Genetics Time Allowed: 1 Hour 30 Minutes Marking Scheme: Total marks available for
More informationInvestigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing
Investigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing Erika Matuschek, Ph D Lead Scientist/Operational Manager EUCAST Development Laboratory (EDL) Växjö, Sweden ASM/ESCMID
More information